Information  X 
Enter a valid email address

Company Name matching 'Infant Bacterial Therapeutics'

Date
Time Source
Company
Announcement
04 May 2022 5:00 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 31, 2022
  3:00 pm GNW   Infant Bacterial Therapeutics Annual General Meeting of Infant Bacterial Therapeutics
05 Apr 2022 7:00 pm GNW   Infant Bacterial Therapeutics Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics
31 Mar 2022 7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics publishes Annual Report for 2021
04 Feb 2022 7:00 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2021
19 Jan 2022 10:30 pm GNW   Infant Bacterial Therapeutics The Connection Study continues after pre-scheduled Data Monitoring Committee (DMC) review
10 Jan 2022 9:30 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics today announces that new patent protection is granted in Australia
27 Dec 2021 9:30 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics today announces new patent protection approvals in Brazil and in Hong Kong
10 Dec 2021 7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics CFO leaves the company
06 Dec 2021 6:47 pm GNW   Infant Bacterial Therapeutics A Blinded Evaluation of the Connection Study – Sustained Feeding Tolerance (SFT) Correlates to Clinical Outcomes
29 Oct 2021 3:15 pm GNW   Infant Bacterial Therapeutics Nomination Committee appointed for the 2022 Annual General Meeting (AGM) in Infant Bacterial Therapeutics (IBT).
  7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ), Interim report January 1-September 30, 2021
30 Sep 2021 6:00 pm GNW   Infant Bacterial Therapeutics Next recruitment milestone reached in IBT’s Phase III Study.
22 Sep 2021 9:30 pm GNW   Infant Bacterial Therapeutics After safety review The Connection study is now again open to recruit the smallest infants.
10 Sep 2021 11:30 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics today announces that a new patent is granted in Mexico
25 Aug 2021 11:50 am GNW   Infant Bacterial Therapeutics Recruitment of the smallest infants in the Connection study paused
13 Aug 2021 7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2021
13 Jul 2021 4:00 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB appoints Marie-Louise Alamaa as new CFO
20 May 2021 3:30 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics CFO leaves the company
06 May 2021 5:50 pm GNW   Infant Bacterial Therapeutics Annual General Meeting of Infant Bacterial Therapeutics CEO speech
04 May 2021 4:00 pm GNW   Infant Bacterial Therapeutics Annual General Meeting of Infant Bacterial Therapeutics
  7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 31, 2021
29 Apr 2021 9:00 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics expands The Connection Study to include infants with a birth weight below 750 grams
15 Apr 2021 6:00 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics receives additional patent protection in China
09 Apr 2021 7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics publishes Annual Report for 2020
01 Apr 2021 2:00 pm GNW   Infant Bacterial Therapeutics Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics
10 Feb 2021 2:00 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics announces that the recruitment to the first stage of the Phase III Connection Study is completed - an update about the clinical development of IBP-9414
09 Feb 2021 7:00 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics today announces that new patent protection is granted in Japan
05 Feb 2021 7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2020
05 Nov 2020 7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – September 30, 2020
14 Aug 2020 7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2020
16 Jun 2020 4:00 pm GNW   Infant Bacterial Therapeutics Annual General Meeting of Infant Bacterial Therapeutics
18 May 2020 8:30 pm GNW   Infant Bacterial Therapeutics Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics
11 May 2020 3:00 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1-March 31, 2020
03 Apr 2020 1:05 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics publishes Annual Report for 2019
  1:00 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB postpones Annual General Meeting
11 Feb 2020 7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2019
07 Nov 2019 7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – September 30, 2019
05 Nov 2019 4:00 pm GNW   Infant Bacterial Therapeutics Lilian Wikström Ph.D. has requested to resign from the Board of Directors of Infant Bacterial Therapeutics AB
21 Aug 2019 7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2019
04 Jul 2019 1:15 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics has recruited the first patient in the pivotal Phase III clinical study
19 May 2019 7:00 pm GNW   Infant Bacterial Therapeutics FDA and Infant Bacterial Therapeutics agree on the design of Phase III study
06 May 2019 5:30 pm GNW   Infant Bacterial Therapeutics Annual General Meeting of Infant Bacterial Therapeutics
  12:00 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 31, 2019
05 Apr 2019 4:30 pm GNW   Infant Bacterial Therapeutics Notice to attend the Annual General Meeting of Infant Bacterial Therapeutics AB (publ)
04 Apr 2019 7:00 pm GNW   Infant Bacterial Therapeutics IBT publishes annual report for 2018
05 Mar 2019 4:10 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB announces first distribution agreement
08 Feb 2019 7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – December 31, 2018
21 Nov 2018 8:45 am GNW   Infant Bacterial Therapeutics The Phase III study protocol is modified after IBT’s meeting with the FDA
14 Nov 2018 7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – September 30, 2018
08 Oct 2018 10:30 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) announces that the Nomination Committee is appointed for the Annual General Meeting 2019
04 Sep 2018 3:20 pm GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics publishes prospectus in connection with the list change to Nasdaq Stockholm
30 Aug 2018 9:30 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics has been approved for listing on the main market of Nasdaq Stockholm
16 Aug 2018 7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2018
26 Jun 2018 7:00 am GNW   Infant Bacterial Therapeutics IBT plans to start its phase 3 study in the second half of 2018 and contracts CRO
15 May 2018 5:00 pm GNW   Infant Bacterial Therapeutics Annual General Meeting of Infant Bacterial Therapeutics AB
  8:47 am GNW   Infant Bacterial Therapeutics Update: Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 30, 2018
  7:00 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – March 30, 2018
09 May 2018 10:30 am GNW   Infant Bacterial Therapeutics Infant Bacterial Therapeutics AB Nomination Committee modifies its proposal to the Board of Directors


Company Announcements Archive »


a d v e r t i s e m e n t